Key result
CardioVeyra proposes an on-device Android rPPG framework for contactless HR and HRV monitoring.
Why the study?
Wearables, pulse oximeters, and clinical equipment usually used to measure heart rate and heart rate variability are not accessible to many people for regular at-home checks, prompting interest in contactless smartphone-based remote photoplethysmography.
This literature survey of 30 studies and theoretical analysis proposes CardioVeyra, an on-device smartphone application using remote photoplethysmography and Edge AI for contactless heart rate and heart rate variability estimation, though no experimental validation results are reported.
Answers are grounded in this paper and cite their sources.
Theoretical rPPG pipeline requires prospective validation before any clinical use; leaves open on-device feasibility for contactless HR/HRV.
Cardiovascular indicators such as Heart Rate (HR) and Heart Rate Variability (HRV) are usually measured with wearables, pulse oximeters, or clinical equipment that many people cannot use for regular, at-home checks. Remote Photoplethysmography (rPPG) offers a contactless alternative by recovering the blood volume pulse from subtle colour changes in facial video. This paper surveys thirty studies published during 2024–2026 on rPPG frameworks and reviews, signal processing, deep learning, regions of interest, video quality, edge deployment, privacy, ethics, and demographic fairness, and uses them to motivate CardioVeyra, a smartphone-based contactless cardiovascular assessment system. CardioVeyra is a native Android application built with Kotlin, CameraX, and Jetpack Compose. It is designed to detect the face on the device, track the forehead Region of Interest (ROI), extract mean RGB values, apply CHROM/POS-based rPPG processing with Butterworth bandpass filtering, and detect pulse peaks with a lightweight TensorFlow Lite model so that HR and HRV can be computed from inter-beat intervals. The theoretical analysis explains each stage of the pipeline together with the validation methodology against pulse-oximeter reference measurements, the privacy design, and the limitations. The survey shows that deep models improve robustness but are costly for mobile use, that HRV demands more accurate peak timing than HR, and that skin-tone bias, illumination, motion, and privacy remain open challenges. CardioVeyra is intended for preliminary monitoring and not for medical diagnosis, and no experimental results are reported.
No takes yet. Share an insight, caveat, or question.
Wakhare et al. (2026) conducted a review in Cardiovascular health assessment (Heart Rate and Heart Rate Variability monitoring). CardioVeyra (smartphone-based contactless rPPG and Edge AI pipeline) vs. Pulse-oximeter reference measurements (theoretical validation) was evaluated on Heart Rate (HR) and Heart Rate Variability (HRV) estimation. CardioVeyra proposes a theoretical on-device Android rPPG pipeline based on a survey of 30 studies (2024–2026) for contactless HR and HRV monitoring, with no experimental results reported.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: